[CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version]
- PMID: 26830296
- DOI: 10.1007/s00393-015-0038-2
[CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version]
Similar articles
-
Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.Front Immunol. 2018 Oct 2;9:2276. doi: 10.3389/fimmu.2018.02276. eCollection 2018. Front Immunol. 2018. PMID: 30333834 Free PMC article. Review.
-
Modulation of B cell regulatory molecules CD22 and CD72 in myasthenia gravis and multiple sclerosis.Inflammation. 2013 Jun;36(3):521-8. doi: 10.1007/s10753-012-9573-z. Inflammation. 2013. PMID: 23184497
-
B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.Arthritis Rheum. 2004 Sep;50(9):2730-41. doi: 10.1002/art.20487. Arthritis Rheum. 2004. PMID: 15457440 Review. No abstract available.
-
B cell inhibitory receptors and autoimmunity.Immunology. 2003 Mar;108(3):263-73. doi: 10.1046/j.1365-2567.2003.01592.x. Immunology. 2003. PMID: 12603592 Free PMC article. Review. No abstract available.
-
Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.Curr Top Microbiol Immunol. 1999;244:57-68. doi: 10.1007/978-3-642-58537-1_5. Curr Top Microbiol Immunol. 1999. PMID: 10453649 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical